MicroRNA‐124‐3p regulates cell proliferation, invasion, apoptosis, and bioenergetics by targeting PIM1 in astrocytoma

The PIM1 protein is an important regulator of cell proliferation, the cell cycle, apoptosis, and metabolism in various human cancers. MicroRNAs (miRNAs) are powerful post‐transcriptional gene regulators that function through translational repression or transcript destabilization. Therefore, we aimed to identify whether a close relationship exists between PIM1 and miRNAs. PIM1 protein levels and mRNA levels were significantly upregulated in astrocytoma tissues, indicating the oncogenic role of PIM1 in astrocytoma. Further bioinformatics analysis indicated that miR‐124‐3p targeted the 3′‐UTR of PIM1. We also observed an inverse correlation between the miR‐124‐3p levels and PIM1 protein or mRNA levels in astrocytoma samples. Next, we experimentally confirmed that miR‐124‐3p directly recognizes the 3′‐UTR of the PIM1 transcript and regulates PIM1 expression at both the protein and mRNA levels. Furthermore, we examined the biological consequences of miR‐124‐3p targeting PIM1 in vitro. We showed that the repression of PIM1 in astrocytoma cancer cells by miR‐124‐3p suppressed proliferation, invasion, and aerobic glycolysis and promoted apoptosis. We observed that the restoration or inhibition of PIM1 activity resulted in effects that were similar to those induced by miR‐124‐3p inhibitors or mimics in cancer cells. Finally, overexpression of PIM1 rescued the inhibitory effects of miR‐124‐3p. In summary, these findings aid in understanding the tumor‐suppressive role of miR‐124‐3p in astrocytoma pathogenesis through the inhibition of PIM1 translation.

[1]  Jianxin Sun,et al.  Pim1 kinase promotes angiogenesis through phosphorylation of endothelial nitric oxide synthase at Ser-633. , 2016, Cardiovascular research.

[2]  Yiqun Cao,et al.  Decreased miR-106a inhibits glioma cell glucose uptake and proliferation by targeting SLC2A3 in GBM , 2013, BMC Cancer.

[3]  A. Kraft,et al.  PIM1 Protein Kinase regulates PRAS40 phosphorylation and mTOR activity in FDCP1 cells , 2009, Cancer biology & therapy.

[4]  Xi Chen,et al.  The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma. , 2010, European journal of cancer.

[5]  Charles Duyckaerts,et al.  The 2007 WHO classification of tumors of the central nervous system – what has changed? , 2008, Current opinion in neurology.

[6]  Erwin G. Van Meir,et al.  Exciting New Advances in Neuro‐Oncology: The Avenue to a Cure for Malignant Glioma , 2010, CA: a cancer journal for clinicians.

[7]  Lizhuang Yang,et al.  MiR-124 inhibits the growth of glioblastoma through the downregulation of SOS1. , 2013, Molecular medicine reports.

[8]  F. Arenas-Huertero,et al.  Reductions in the expression of miR-124-3p, miR-128-1, and miR-221-3p in pediatric astrocytomas are related to high-grade supratentorial, and recurrent tumors in Mexican children , 2014, Child's Nervous System.

[9]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[10]  W. Sellers,et al.  TSC 2 regulates VEGF through mTOR-dependent and-independent pathways , 2003 .

[11]  Xingjun Jiang,et al.  miR-124a restoration inhibits glioma cell proliferation and invasion by suppressing IQGAP1 and β-catenin. , 2014, Oncology reports.

[12]  Andrea Sottoriva,et al.  The shaping and functional consequences of the microRNA landscape in breast cancer , 2013, Nature.

[13]  C. Bieberich,et al.  Stabilization of the prostate‐specific tumor suppressor NKX3.1 by the oncogenic protein kinase Pim‐1 in prostate cancer cells , 2013, Journal of cellular biochemistry.

[14]  Anton J. Enright,et al.  Human MicroRNA Targets , 2004, PLoS biology.

[15]  C. Burge,et al.  Prediction of Mammalian MicroRNA Targets , 2003, Cell.

[16]  Xiaohong Wang,et al.  MicroRNA-486-5p targeting PIM-1 suppresses cell proliferation in breast cancer cells , 2014, Tumor Biology.

[17]  C. Harris,et al.  Genetic variation in microRNA networks: the implications for cancer research , 2010, Nature Reviews Cancer.

[18]  Yilin Yang,et al.  miR-106a-5p Inhibits the Proliferation and Migration of Astrocytoma Cells and Promotes Apoptosis by Targeting FASTK , 2013, PloS one.

[19]  Chuan Jin,et al.  CDA-2 induces cell differentiation through suppressing Twist/SLUG signaling via miR-124 in glioma , 2012, Journal of Neuro-Oncology.

[20]  M. Esteller Non-coding RNAs in human disease , 2011, Nature Reviews Genetics.

[21]  D. Su,et al.  An updated role of microRNA-124 in central nervous system disorders: a review , 2015, Front. Cell. Neurosci..

[22]  S. Green,et al.  GliaSite Brachytherapy for Treatment of Recurrent Malignant Gliomas: A Retrospective Multi-institutional Analysis , 2006, Neurosurgery.

[23]  William R Sellers,et al.  TSC2 regulates VEGF through mTOR-dependent and -independent pathways. , 2003, Cancer cell.

[24]  M. Minden,et al.  The Pim-1 Protein Kinase Is an Important Regulator of MET Receptor Tyrosine Kinase Levels and Signaling , 2014, Molecular and Cellular Biology.

[25]  A. Minn,et al.  MicroRNA-124 expression counteracts pro-survival stress responses in glioblastoma , 2014, Oncogene.

[26]  J. Ai,et al.  miR-143 inhibits glycolysis and depletes stemness of glioblastoma stem-like cells. , 2013, Cancer letters.

[27]  T. Jiang,et al.  MiR-124 governs glioma growth and angiogenesis and enhances chemosensitivity by targeting R-Ras and N-Ras. , 2014, Neuro-oncology.

[28]  D. Gutsch,et al.  The proto-oncogene Pim-1 is a target of miR-33a , 2012, Oncogene.

[29]  Yi Huang,et al.  miR-495 Mediates Metabolic Shift in Glioma Cells via Targeting Glut1 , 2015, The Journal of craniofacial surgery.

[30]  L. Kopper,et al.  Tumor stem cells , 2008, Pathology & Oncology Research.

[31]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[32]  S. Knapp,et al.  PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma , 2012, British Journal of Cancer.

[33]  Kye-Seong Kim,et al.  miR‐124a Is Important for Migratory Cell Fate Transition During Gastrulation of Human Embryonic Stem Cells , 2010, Stem cells.

[34]  I. Ng,et al.  PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma , 2015, Oncotarget.

[35]  Santosh Kesari,et al.  Malignant gliomas in adults. , 2008, The New England journal of medicine.

[36]  Carmen Blanco-Aparicio,et al.  The PIM Family of Serine/Threonine Kinases in Cancer , 2014, Medicinal research reviews.

[37]  Michael C. Ostrowski,et al.  MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells. , 2010, Molecular cell.

[38]  Wei-hua Zhao,et al.  Downregulation of miR-124 promotes the growth and invasiveness of glioblastoma cells involving upregulation of PPP1R13L. , 2013, International journal of molecular medicine.

[39]  Arto Mannermaa,et al.  Proto-oncogene PIM-1 is a novel estrogen receptor target associating with high grade breast tumors , 2013, Molecular and Cellular Endocrinology.

[40]  Claudia Petritsch,et al.  miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells , 2008 .

[41]  P. Ward,et al.  Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. , 2012, Cancer cell.

[42]  T. Liang,et al.  Gap Junctions Enhance the Antiproliferative Effect of MicroRNA‐124‐3p in Glioblastoma Cells , 2015, Journal of cellular physiology.

[43]  Bin Xu,et al.  miR‐124 exerts tumor suppressive functions on the cell proliferation, motility and angiogenesis of bladder cancer by fine‐tuning UHRF1 , 2015, The FEBS journal.

[44]  Teng Chen,et al.  Downregulation of microRNA-124 predicts poor prognosis in glioma patients , 2014, Neurological Sciences.

[45]  L. You,et al.  PIM kinases: an overview in tumors and recent advances in pancreatic cancer. , 2014, Future oncology.

[46]  Gang Lu,et al.  Loss of Brain-enriched miR-124 MicroRNA Enhances Stem-like Traits and Invasiveness of Glioma Cells* , 2012, The Journal of Biological Chemistry.

[47]  Yan Zhu,et al.  Activated β-catenin Forces N2A Cell-derived Neurons Back to Tumor-like Neuroblasts and Positively Correlates with a Risk for Human Neuroblastoma , 2012, International journal of biological sciences.

[48]  Ru-jia Li,et al.  Inhibition of Pim-1 attenuates the proliferation and migration in nasopharyngeal carcinoma cells. , 2012, Asian Pacific journal of tropical medicine.

[49]  Y. Guan,et al.  microRNA-124 Inhibits Migration and Invasion by Down-Regulating ROCK1 in Glioma , 2013, PloS one.

[50]  X. Wang,et al.  Role of micro-RNA (miRNA) in pathogenesis of glioblastoma. , 2015, European review for medical and pharmacological sciences.

[51]  Jian Sun,et al.  MicroRNA-7 directly targets insulin-like growth factor 1 receptor to inhibit cellular growth and glucose metabolism in gliomas , 2014, Diagnostic Pathology.

[52]  D. Bartel MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[53]  Yilin Yang,et al.  MiR-181b-5p Downregulates NOVA1 to Suppress Proliferation, Migration and Invasion and Promote Apoptosis in Astrocytoma , 2014, PloS one.

[54]  Y. Mao,et al.  miR-124 suppresses the migration and invasion of glioma cells in vitro via Capn4. , 2016, Oncology reports.

[55]  Wanyeon Kim,et al.  PIM1 kinase inhibitors induce radiosensitization in non-small cell lung cancer cells. , 2013, Pharmacological research.